Changes

The U.S. government will regulate the recombinant DNA in the salmon as a New Animal Drug (NAD). Thus, it falls under the regulatory authority of the FDA. A few weeks after issuing its initial finding that the GE salmon is safe to eat, the FDA will hold held two public meetings on the issue September 19-21, 2010.<ref>[http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm224089.htm Public Meetings on Genetically Engineered Atlantic Salmon], U.S. FDA, Accessed September 7, 2010.</ref> The first, a meeting of the FDA's [[Veterinary Medicine Advisory Committee]] (VMAC) will take took place September 19-20, addressing the scientific issues associated with the approval of GE salmon. The second, a public hearing in which the FDA will present presented the legal principles for food labeling and offer offered the public an opportunity to comment, will take took place on September 21, 2010. Prior to the meetings, the FDA released a number of documents, including a briefing packet for the VMAC meeting describing the science used to determine the GE salmon's safety.<ref>[http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/VeterinaryMedicineAdvisoryCommittee/UCM224762.pdf Briefing Packet for AquAdvantage Salmon Veterinary Medicine Advisory Committee (PDF - 2506KB)], U.S. FDA.</ref>